These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Zebrafish: a new model on the pharmaceutical catwalk. Langheinrich U Bioessays; 2003 Sep; 25(9):904-12. PubMed ID: 12938180 [TBL] [Abstract][Full Text] [Related]
4. Small molecule screening in the zebrafish. Murphey RD; Zon LI Methods; 2006 Jul; 39(3):255-61. PubMed ID: 16877005 [TBL] [Abstract][Full Text] [Related]
5. Zebrafish: from disease modeling to drug discovery. Rubinstein AL Curr Opin Drug Discov Devel; 2003 Mar; 6(2):218-23. PubMed ID: 12669457 [TBL] [Abstract][Full Text] [Related]
6. In vivo drug discovery in the zebrafish. Zon LI; Peterson RT Nat Rev Drug Discov; 2005 Jan; 4(1):35-44. PubMed ID: 15688071 [TBL] [Abstract][Full Text] [Related]
7. Chemical genetics: Drug screens in Zebrafish. den Hertog J Biosci Rep; 2005; 25(5-6):289-97. PubMed ID: 16307377 [TBL] [Abstract][Full Text] [Related]
8. Biophysical properties of zebrafish ether-à-go-go related gene potassium channels. Scholz EP; Niemer N; Hassel D; Zitron E; Bürgers HF; Bloehs R; Seyler C; Scherer D; Thomas D; Kathöfer S; Katus HA; Rottbauer WA; Karle CA Biochem Biophys Res Commun; 2009 Apr; 381(2):159-64. PubMed ID: 19232322 [TBL] [Abstract][Full Text] [Related]
9. Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption. Segner H Comp Biochem Physiol C Toxicol Pharmacol; 2009 Mar; 149(2):187-95. PubMed ID: 18955160 [TBL] [Abstract][Full Text] [Related]
10. Technology for high-throughput screens: the present and future using zebrafish. Love DR; Pichler FB; Dodd A; Copp BR; Greenwood DR Curr Opin Biotechnol; 2004 Dec; 15(6):564-71. PubMed ID: 15560983 [TBL] [Abstract][Full Text] [Related]
11. Induction of reversible hemolytic anemia in living zebrafish using a novel small molecule. Shafizadeh E; Peterson RT; Lin S Comp Biochem Physiol C Toxicol Pharmacol; 2004 Jul; 138(3):245-9. PubMed ID: 15533782 [TBL] [Abstract][Full Text] [Related]
12. Genomic and functional conservation of sedative-hypnotic targets in the zebrafish. Renier C; Faraco JH; Bourgin P; Motley T; Bonaventure P; Rosa F; Mignot E Pharmacogenet Genomics; 2007 Apr; 17(4):237-53. PubMed ID: 17496723 [TBL] [Abstract][Full Text] [Related]
13. Relevance of in vitro SCREENIT results for drug-induced QT interval prolongation in vivo: a database review and analysis. Dumotier BM; Deurinck M; Yang Y; Traebert M; Suter W Pharmacol Ther; 2008 Aug; 119(2):152-9. PubMed ID: 18462801 [TBL] [Abstract][Full Text] [Related]
14. The use of the zebrafish model in stress research. Steenbergen PJ; Richardson MK; Champagne DL Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1432-51. PubMed ID: 20971150 [TBL] [Abstract][Full Text] [Related]
15. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment. Seng WL; Eng K; Lee J; McGrath P Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologically induced angiogenesis in transgenic zebrafish. Raghunath M; Sy Wong Y; Farooq M; Ge R Biochem Biophys Res Commun; 2009 Jan; 378(4):766-71. PubMed ID: 19068208 [TBL] [Abstract][Full Text] [Related]
17. The power of the zebrafish for disease analysis. Ingham PW Hum Mol Genet; 2009 Apr; 18(R1):R107-12. PubMed ID: 19297397 [TBL] [Abstract][Full Text] [Related]
18. Zebrafish assays for drug toxicity screening. Rubinstein AL Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):231-40. PubMed ID: 16866609 [TBL] [Abstract][Full Text] [Related]
19. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Murphey RD; Stern HM; Straub CT; Zon LI Chem Biol Drug Des; 2006 Oct; 68(4):213-9. PubMed ID: 17105485 [TBL] [Abstract][Full Text] [Related]
20. Cardio-respiratory control during early development in the model animal zebrafish. Schwerte T Acta Histochem; 2009; 111(3):230-43. PubMed ID: 19121852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]